Thomas Jerfferson University Hospital SC
Welcome,         Profile    Billing    Logout  
 4 Trials 
3 Trials

   Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Sato, Takami
NCT02068586: Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma

Active, not recruiting
2
210
US
Sunitinib, Sunitinib malate, Sutent, SU11248, 341031-54-7 Butanedioic acid, Valproic Acid, VPA, Valproate, Valproate sodium, Depakote, Epilim, Valparin, Valpro, Stavzor, Depakene, Di-n-propylacetic Acid, Sunitinib Malate, sunitinib, SU011248, Sunitinib Malate + Valproic Acid
Sidney Kimmel Cancer Center at Thomas Jefferson University, Pfizer
Ciliary Body and Choroid Melanoma, Medium/Large Size, Ciliary Body and Choroid Melanoma, Small Size, Iris Melanoma, Stage I Intraocular Melanoma, Stage IIA Intraocular Melanoma, Stage IIB Intraocular Melanoma, Stage IIIA Intraocular Melanoma, Stage IIIB Intraocular Melanoma, Stage IIIC Intraocular Melanoma, Stage I Uveal Melanoma AJCC V7, Stage II Uveal Melanoma AJCC V7, Stage III Uveal Melanoma AJCC V7
12/25
12/25
17P.641, NCT03405155: Nivolumab in Treating Patients With Stage IIB-IIC Melanoma That Can Be Removed by Surgery

Active, not recruiting
2
26
US
Nivolumab, BMS-936558, NIVO, Opdivo, ONO-4538
Sidney Kimmel Cancer Center at Thomas Jefferson University, Bristol-Myers Squibb
Melanoma (Skin)
12/24
12/25
IMC-F106C-101, NCT04262466 / 2019-004046-16: Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors

Hourglass Oct 2024 - Dec 2024 : Data for late-line NSCLC
Recruiting
1/2
727
Europe, Canada, US, RoW
Brenetafusp, Brenetafusp and pembrolizumab, Brenetafusp and chemotherapy, Brenetafusp and monoclonal antibodies and chemotherapy, Brenetafusp and tebentafusp, Brenetafusp and bevacizumab, Brenetafusp and kinase inhibitors
Immunocore Ltd
Select Advanced Solid Tumors
02/26
08/26
Feeney, Kendra
No trials found
Sailor, Linda
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Sato, Takami
NCT02068586: Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma

Active, not recruiting
2
210
US
Sunitinib, Sunitinib malate, Sutent, SU11248, 341031-54-7 Butanedioic acid, Valproic Acid, VPA, Valproate, Valproate sodium, Depakote, Epilim, Valparin, Valpro, Stavzor, Depakene, Di-n-propylacetic Acid, Sunitinib Malate, sunitinib, SU011248, Sunitinib Malate + Valproic Acid
Sidney Kimmel Cancer Center at Thomas Jefferson University, Pfizer
Ciliary Body and Choroid Melanoma, Medium/Large Size, Ciliary Body and Choroid Melanoma, Small Size, Iris Melanoma, Stage I Intraocular Melanoma, Stage IIA Intraocular Melanoma, Stage IIB Intraocular Melanoma, Stage IIIA Intraocular Melanoma, Stage IIIB Intraocular Melanoma, Stage IIIC Intraocular Melanoma, Stage I Uveal Melanoma AJCC V7, Stage II Uveal Melanoma AJCC V7, Stage III Uveal Melanoma AJCC V7
12/25
12/25
17P.641, NCT03405155: Nivolumab in Treating Patients With Stage IIB-IIC Melanoma That Can Be Removed by Surgery

Active, not recruiting
2
26
US
Nivolumab, BMS-936558, NIVO, Opdivo, ONO-4538
Sidney Kimmel Cancer Center at Thomas Jefferson University, Bristol-Myers Squibb
Melanoma (Skin)
12/24
12/25
IMC-F106C-101, NCT04262466 / 2019-004046-16: Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors

Hourglass Oct 2024 - Dec 2024 : Data for late-line NSCLC
Recruiting
1/2
727
Europe, Canada, US, RoW
Brenetafusp, Brenetafusp and pembrolizumab, Brenetafusp and chemotherapy, Brenetafusp and monoclonal antibodies and chemotherapy, Brenetafusp and tebentafusp, Brenetafusp and bevacizumab, Brenetafusp and kinase inhibitors
Immunocore Ltd
Select Advanced Solid Tumors
02/26
08/26
Feeney, Kendra
No trials found
Sailor, Linda
No trials found

Download Options